Peter S Ringrose - Net Worth and Insider Trading

Peter S Ringrose Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter S Ringrose owns 3 companies in total, including Theravance Biopharma Inc (TBPH) , Rigel Pharmaceuticals Inc (RIGL) , and Innoviva Inc (INVA) .

Click here to see the complete history of Peter S Ringrose’s form 4 insider trades.

Insider Ownership Summary of Peter S Ringrose

Ticker Comapny Transaction Date Type of Owner
TBPH Theravance Biopharma Inc 2014-05-14 director
RIGL Rigel Pharmaceuticals Inc 2005-02-02 director
INVA Innoviva Inc 2010-04-27 director

Peter S Ringrose Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Peter S Ringrose Ownership Network

Ownership Network List of Peter S Ringrose

No Data

Ownership Network Relation of Peter S Ringrose

Insider Network Chart

Peter S Ringrose Owned Company Details

What does Theravance Biopharma Inc do?

Who are the key executives at Theravance Biopharma Inc?

Peter S Ringrose is the director of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include 10 percent owner Eli Samaha , SVP & Comm & Medical Affairs Rhonda Farnum , and SVP & Development Richard A Graham .

Theravance Biopharma Inc (TBPH) Insider Trades Summary

Over the past 18 months, Peter S Ringrose made no insider transaction in Theravance Biopharma Inc (TBPH). Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 19,057 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 2,498,924 shares made by Eli Samaha .

In summary, during the past 3 months, insiders sold 4,000 shares of Theravance Biopharma Inc (TBPH) in total and bought 999,800 shares, with a net purchase of 995,800 shares. During the past 18 months, 29,286 shares of Theravance Biopharma Inc (TBPH) were sold and 2,498,924 shares were bought by its insiders, resulting in a net purchase of 2,469,638 shares.

Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Theravance Biopharma Inc Insider Transactions

No Available Data

Peter S Ringrose Mailing Address

Above is the net worth, insider trading, and ownership report for Peter S Ringrose. You might contact Peter S Ringrose via mailing address: C/o Bristol Myers Squibb Co, 345 Park Ave, New York Ny 10164.

Discussions on Peter S Ringrose

No discussions yet.